Etripamil nasal spray

The safety and tolerability of etripamil, an investigational nasal spray for paroxysmal supraventricular tachycardia (PSVT), are maintained

CARDAMYST (etripamil) nasal spray, the conditionally approved brand name for etripamil nasal spray, is well studied with a robust clinical trial program that includes a completed Phase 3

In a new study, etripamil, a rapid- and short-acting investigational medication formulated to be delivered via nasal spray, restored a normal

Apomorphine, a non-ergoline dopamine agonist, is believed to siteName MPR siteURL siteID 7 Etripamil Nasal Spray

Etripamil is an investigational, self-administered, intranasal etripamil nasal spray for the treatment of paroxysmal supraventricular

Etripamil Nasal Spray for Patients with Paroxysmal Supraventricular Tachycardia (NODE-303 Etripamil Clinical Research in PSVT). Principal Investigator: Marco

Etripamil is Milestone's lead investigational product. It is a novel calcium channel blocker nasal spray being developed for elevated and often

CARDAMYST, the conditionally approved brand name for etripamil nasal spray, is well studied with a robust clinical trial program that

Etripamil nasal spray shows promise for treating PSVT at home.